Banaras Hindu University Conducts Research on Economical Anti-Diabetic Drugs

Diabetes research is being conducted by the faculty and research students of Banaras Hindu University (BHU).

Banaras Hindu University (BHU) faculties and research students are doing a vital research on diabetes to provide low-cost drugs.

The central university will carry out a research on cost-effective anti-diabetic drugs through new routes for which the Central government and the Union Education Ministry have sanctioned Rs. 40 lakh.

COVID-19 Increases Sales of Cardiac, Anti-diabetic Drugs
The changes in the medication needs of the masses due to the novel Coronavirus pandemic seems to impacting the operation of pharmaceutical companies with those dealing in various therapies.

‘Banaras Hindu University (BHU) will also if polyphenols combined with carbohydrates can treat different viral infections, including Covid-19.’

Nazar Hussain, assistant professor, department of medicinal chemistry, Faculty of Ayurveda, Institute of Medical Sciences, BHU, has bagged the much coveted project by Science and Engineering Research Board, a statutory body of the Department of Science and Technology, Government of India, on C-glycosides synthesis.

Hussain said that C-glycosides are the derivatives of carbohydrates which are widely used in the treatment of diabetes.

He will be receiving a grant of more than Rs. 40 lakh for his research in this project. Under this project he will be carrying out research on anti-diabetic drugs through new routes in a cost-effective manner.

Scientists Find New Functional Details of Common Anti-Diabetic Drugs
Scientists thought that they basically knew how the most common drugs used to treat type 2 diabetes worked.

Along with the synthesis of anti-diabetic drugs, the project also aims at synthesizing some polyphenolic C-glycosides. Polyphenolic compounds are known in the treatment of various viral infections.

This study will also explore the possibility of combining polyphenols with carbohydrates to test their anti-viral activities against different viral infections, including Covid-19. This will be one of the major studies of its kind in the country.

Anti-diabetic Drugs may Increase the Risk of Inflammatory Bowel Disease
A type of antidiabetic drug called dipeptidyl peptidase-4 inhibitors are associated with the incidence of inflammatory bowel disease in patients with type 2 diabetes. Physicians should be made aware of this possible association.

For BHU, it is a matter of great pride as the Department of Medicinal Chemistry has been given a project of such vital importance and significance.

Source-IANS

Microbiome in Gut Affects Responses to Anti-diabetic Drugs
Gut microbiome influences the metabolism of the antidiabetic drugs which cause variation in the patient's therapeutic response